White Papers
-
Open-Label Study Assessing Relative And Absolute Bioavailability
1/26/2026
Consistent absorption across different formulations and dietary conditions ensures stable therapeutic exposure. This flexibility simplifies patient dosing schedules and supports manufacturing transitions.
-
Improving The eCOA Experience
1/25/2026
Discover how template-driven builds and reuse can slash eCOA timelines by 50% while solving the licensing and translation hurdles that delay First Patient In.
-
Serbia: Europe's Emerging Clinical Trial Powerhouse
1/22/2026
Discover why Serbia is becoming a top strategic choice for sponsors, including details of the country's strengths in key therapeutic areas, streamlined processes, and operational advantages.
-
What the FDA Looks For In Global Development Programs Today
1/16/2026
Mastering the complexities of multi-regional clinical trials requires aligning global data with evolving regulatory expectations to ensure treatment consistency and successful drug approval.
-
Beyond The Benchmark: Innovative Trial Designs Transform Research
1/15/2026
Adaptive designs, decentralized models, and AI insights are reshaping trials — boosting efficiency, speeding timelines, and strengthening evidence amid evolving regulations and funding pressures.
-
Empower Your Trial With Data And Evidence
1/14/2026
Fuel your clinical development and decision-making with insights from fit-for-purpose data and evidence.
-
A New, AI-Augmented Horizon For Safety And Pharmacovigilance
1/6/2026
Is your organization leveraging AI to maximize efficiency in safety and regulatory workflows? If not, explore how these technologies are slated to improve industry approaches in 2026.
-
Addressing Trial Design Hurdles Across Alzheimer’s Disease Stages
12/10/2025
Explore how endpoint selection, rater training, and the strategic implementation of eCOA can help address the unique scientific, operational, and human considerations at each stage of AD.
-
Digital Endpoint Resource Guide: Sleep Disorders
12/10/2025
Sensor-driven digital endpoints track sleep patterns and disruptions, standardize trial outcomes, and enable remote monitoring that reduces patient burden while improving treatment-response insights.
-
Clinical Trial Starts Rose At Slower Pace In 2024
12/8/2025
Clinical trial starts grew 5.5% to 10,503 in 2024, a slowdown from 2023’s 9.4% rise in trial starts. Sustained geopolitical and global regulatory pressures on pharma contributed to curbing momentum.